Vero Biosciences
You are only as young as your oldest organ
- Employees
- 1–10
- Business Model
- B2B
- Website
- verobioscience.com
- Last Round
- Seed
- Rounds
- 1
About
Vero Biosciences is a longevity diagnostics company that uses AI-powered proteomics and machine learning to measure the biological age of individual organs from a single blood draw. Developed on research from Stanford University involving 45,000+ individuals over 15 years, Vero's Proteomic OrganAge platform analyzes 11,000+ proteins with organ-specific signatures to detect accelerated aging years before traditional clinical markers appear. The company's Vero Compass platform integrates biological, clinical, and wearable data to guide precise organ-targeted interventions and extend healthspan.
Summary
Vero Biosciences is an Artificial Intelligence company based in United States. Investors include Khosla Ventures.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Unknown
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
Databricks is the pioneer of the data lakehouse, a unified platform for data science, machine lea...